[go: up one dir, main page]

PE20221588A1 - Degradador selectivo del receptor de estrogeno - Google Patents

Degradador selectivo del receptor de estrogeno

Info

Publication number
PE20221588A1
PE20221588A1 PE2022000135A PE2022000135A PE20221588A1 PE 20221588 A1 PE20221588 A1 PE 20221588A1 PE 2022000135 A PE2022000135 A PE 2022000135A PE 2022000135 A PE2022000135 A PE 2022000135A PE 20221588 A1 PE20221588 A1 PE 20221588A1
Authority
PE
Peru
Prior art keywords
estrogen receptor
selective estrogen
receptor degrader
chromen
azetidin
Prior art date
Application number
PE2022000135A
Other languages
English (en)
Inventor
Ranjan Kumar Pal
Biswajit Samanta
Jayraj Dilipbhai Aradhye
Sandeep Pankajkumar Pathak
Kaushik Dhanjibhai Prajapati
Bhavesh Mohanbhai Panchal
Trinadha Rao Chitturi
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of PE20221588A1 publication Critical patent/PE20221588A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un degradador selectivo del receptor de estrogeno (SERD), un compuesto 3-(3,5-difluorofenil)-2-[4-[(E)-3-[3-(fluorometil)azetidin-1-il]prop-1-enil]fenil]-4-metil-2H-cromen-7-ol y su enantiomero S, (2S)-3-(3,5-difluorofenil)-2-[4-[(E)-3-[3-(fluorometil)azetidin-1-il]prop-1-enil]fenil]-4-metil-2H-cromen-7-ol, o sales farmaceuticamente aceptables de estos. Tambien se proporcionan procesos para su preparacion. Tambien se proporciona el uso de estos compuestos para el tratamiento de enfermedades relacionadas con la modulacion de los receptores de estrogeno, tales como el cancer de mama positivo para ER.
PE2022000135A 2019-07-22 2020-07-22 Degradador selectivo del receptor de estrogeno PE20221588A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201921029554 2019-07-22
PCT/IB2020/056914 WO2021014386A1 (en) 2019-07-22 2020-07-22 Selective estrogen receptor degrader

Publications (1)

Publication Number Publication Date
PE20221588A1 true PE20221588A1 (es) 2022-10-10

Family

ID=71842730

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2022000135A PE20221588A1 (es) 2019-07-22 2020-07-22 Degradador selectivo del receptor de estrogeno

Country Status (15)

Country Link
US (2) US11014915B2 (es)
EP (1) EP4003525A1 (es)
JP (1) JP2022541938A (es)
KR (1) KR20220046586A (es)
CN (1) CN114302879A (es)
AU (1) AU2020317099A1 (es)
BR (1) BR112022001285A2 (es)
CA (1) CA3148592A1 (es)
CL (1) CL2022000156A1 (es)
IL (1) IL290036A (es)
MX (1) MX2022001013A (es)
PE (1) PE20221588A1 (es)
PH (1) PH12022550182A1 (es)
WO (1) WO2021014386A1 (es)
ZA (1) ZA202201157B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3111466A1 (en) * 2018-09-07 2020-03-12 Sanofi Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate and preparation process thereof
MX420421B (es) 2019-07-22 2025-02-10 Boehringer Ingelheim Int Derivados de n-(6-metoxi)pirizadin-3-il) amina, n-metilo como moduladores de autotaxina (atx) para el tratamiento de enfermedades inflamatorias de las vias respiratorias o fibroticas
PE20221588A1 (es) * 2019-07-22 2022-10-10 Sun Pharma Advanced Res Co Ltd Degradador selectivo del receptor de estrogeno
AU2023216654B2 (en) * 2022-02-01 2025-09-25 Eli Lilly And Company Processes for the preparation of selective estrogen receptor degraders
CN119176799B (zh) * 2024-09-19 2025-10-03 晨伫(杭州)生物科技有限责任公司 色烯衍生物及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
DE69023906T2 (de) 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrane und Verfahren zu deren Herstellung.
US6060503A (en) 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US5389646A (en) 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
WO1999002512A1 (en) 1997-07-09 1999-01-21 Novo Nordisk A/S Dl-2,3-diaryl-2h-1-benzopyrans
DE10013782A1 (de) 2000-03-15 2001-10-18 Schering Ag 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
MX2012014431A (es) 2010-06-10 2013-02-26 Aragon Pharmaceuticals Inc Modulares del receptor de estrogenos y usos de los mismos.
JP2015500346A (ja) 2011-12-14 2015-01-05 セラゴン ファーマシューティカルズ，インク． エストロゲン受容体モジュレーターおよびその使用
MX2014007198A (es) 2011-12-16 2014-10-13 Olema Pharmaceuticals Inc Compuestos novedosos de benzopirano, composiciones y usos de los mismos.
BR112015030595A2 (pt) 2013-06-19 2017-07-25 Seragon Pharmaceuticals Inc moduladores de receptor de estrogênio de azetidina e usos dos mesmos
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
WO2014203132A1 (en) 2013-06-19 2014-12-24 Olema Pharmaceuticals, Inc. Substituted benzopyran compounds, compositions and uses thereof
CN103879283B (zh) * 2014-03-10 2019-01-15 浙江吉利汽车研究院有限公司 一种电动车辆
JP2017538727A (ja) * 2014-12-18 2017-12-28 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 癌の治療に有用な２，３−ジフェニルクロメンの誘導体
WO2016174551A1 (en) 2015-04-27 2016-11-03 Pfizer Inc. Anti-estrogenic compounds
EP3303326B1 (en) 2015-05-26 2020-12-16 H. Hoffnabb-La Roche Ag Heterocyclic estrogen receptor modulators and uses thereof
ES2916223T3 (es) * 2015-10-27 2022-06-29 Sun Pharma Advanced Res Co Ltd Nuevos antiestrógenos heterocíclicos
PE20221588A1 (es) * 2019-07-22 2022-10-10 Sun Pharma Advanced Res Co Ltd Degradador selectivo del receptor de estrogeno

Also Published As

Publication number Publication date
PH12022550182A1 (en) 2022-11-14
JP2022541938A (ja) 2022-09-28
US20210261534A1 (en) 2021-08-26
EP4003525A1 (en) 2022-06-01
CA3148592A1 (en) 2021-01-28
BR112022001285A2 (pt) 2022-03-22
IL290036A (en) 2022-03-01
KR20220046586A (ko) 2022-04-14
WO2021014386A1 (en) 2021-01-28
CL2022000156A1 (es) 2022-11-18
US11014915B2 (en) 2021-05-25
US20210024504A1 (en) 2021-01-28
CN114302879A (zh) 2022-04-08
AU2020317099A1 (en) 2022-02-24
MX2022001013A (es) 2022-02-22
ZA202201157B (en) 2023-07-26

Similar Documents

Publication Publication Date Title
PE20221588A1 (es) Degradador selectivo del receptor de estrogeno
MX2021009569A (es) Procesos y compuestos.
PH12021550296A1 (en) Substituted indoles and methods of use thereof
MX2023010043A (es) Moduladores del receptor de androgenos y metodos para su uso.
MX392461B (es) Moduladores de receptores estrogénicos
EA201791239A1 (ru) ТЕТРАГИДРОПИРИДО[3,4-b]ИНДОЛОВЫЕ МОДУЛЯТОРЫ ЭСТРОГЕНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
PH12021550381A1 (en) Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
EA201391491A1 (ru) Производные 2-(2,4,5-замещенного анилино)пиримидина в качестве модуляторов egfr, полезных для лечения рака
UY32350A (es) Régimen de dosificación de un agonista de los receptores de s1p
ZA202301275B (en) Indole compounds as androgen receptor modulators
EP4212532A3 (en) Mitragynine analogs and uses thereof
UY33118A (es) Indazoles aminotiazolona sustituidos como moduladores del receptor a relacionado con estrógenos
AU2017268006A1 (en) Benzenesulfonamide compounds and their use as therapeutic agents
PE20160050A1 (es) Inhibidores/ antiandrogenos novedosos de cyp17
MX2019006697A (es) Compuestos de bencenosulfonamida y su uso como agentes terapeuticos.
MX2017013877A (es) Compuestos de benzimidazolona y benzotiazolona y su uso como moduladores del receptor ampa.
JOP20200304A1 (ar) مركبات بنزينسلفوناميد واستخدامها كعوامل علاجية
MX377304B (es) Derivados de piperazina como moduladores de los receptores x del hígado.
MX2022005749A (es) Inhibidores de egfr alostericos y metodos de uso de los mismos.
PH12020551297A1 (en) Compounds having s1p5 receptor agonistic activity
WO2019123482A8 (en) Pharmaceutical composition for the treatment of cancer
ECSP088878A (es) Proceso para la preparación de indazolil ureas que inhiben receptores de vanilloides del subtipo 1 (vr1)
MX2021007687A (es) Sales novedosas de degradadores selectivos de receptores de estrogeno.
PH12021551437A1 (en) Estrogen receptor antagonist
MX2017014145A (es) Moduladores selectivos de la actividad del receptor gpr55: derivados de cromenopirazol.